Table.
Time After Hospital Admission, mo | Summary of All Treatment Modalities and Antibody Titers | Serum Antibodya | CSF Antibodya |
---|---|---|---|
1 | Diagnostic lumbar puncture | 1:102 400 | 1:10 240 |
1.5 | Teratoma resection and oophorectomy | ||
2 | IVIg | ||
2 | Methylprednisolone | ||
2–3 | Rituximab | ||
4 | Diagnostic lumbar puncture | 1:51 200 | 1:5120 |
6, 7, and 8 | Cyclophosphamide | ||
8–9 | Rituximab | ||
10 | Diagnostic lumbar puncture | 1:25 600 | 1:2560 |
11 | Cyclophosphamide | ||
12 | Plasmapheresis | ||
12 | Diagnostic lumbar puncture | 1:51 200 | 1:5120 |
13–16 | Intravenous high-dose methotrexate | ||
16 | Rituximab | ||
16 | Diagnostic lumbar puncture | 1:25 600 | 1:5120 |
18 | Electroconvulsive shock | ||
20 | Cyclophosphamide | ||
20 | IVIg | ||
22 | Cyclophosphamide | ||
22 | IVIg |
Abbreviations: CSF, cerebrospinal fluid; IVIg, intravenous immunoglobulin.
Antibody titers were determined using serial dilutions of serum and CSF on rat brain tissue and human embryonic kidney cells expressing NR1 subunits of the N-methyl-D-aspartate receptor. The titer reflects the highest dilution at which reactivity was visible.